Public hearing set on health foundation tied to Summa sale


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Akron residents can share opinions about the new nonprofit health foundation being created from Summa''s sale to General Catalyst.

Public Hearing Scheduled for Health Foundation Linked to Summa Health Sale
In a significant development for Ohio's healthcare landscape, state officials have announced a public hearing to discuss the creation of a new health foundation stemming from the controversial sale of Summa Health, one of the region's largest nonprofit hospital systems. The hearing, set for later this month, aims to gather input from community members, healthcare advocates, and stakeholders on how the foundation will manage and distribute funds generated from the transaction. This move comes amid ongoing scrutiny over the sale's implications for patient care, local economies, and the broader nonprofit healthcare sector in Northeast Ohio.
Summa Health, based in Akron, has long been a cornerstone of medical services in Summit County and surrounding areas, operating hospitals, emergency rooms, and outpatient facilities that serve hundreds of thousands of residents annually. The system, which traces its roots back to the early 20th century, faced mounting financial pressures in recent years, including rising operational costs, shifts in patient volumes due to the COVID-19 pandemic, and competition from larger national chains. These challenges culminated in a landmark decision earlier this year when Summa's board approved a sale to HATCo, a for-profit entity backed by venture capital firm General Catalyst. The deal, valued at over $1 billion, marked one of the most high-profile conversions of a nonprofit health system to for-profit status in recent memory.
Under Ohio law, when a nonprofit hospital like Summa is sold, the proceeds must be directed toward charitable purposes, often through the establishment of a conversion foundation. This ensures that the community's investment in the nonprofit entity continues to benefit public health initiatives. In this case, the proposed foundation—tentatively named the Summa Health Foundation—would receive the net proceeds from the sale after debts and other obligations are settled. Estimates suggest the foundation could be endowed with anywhere from $500 million to $800 million, making it one of the largest health-focused philanthropies in the state. Its mission would likely include funding grants for community health programs, medical research, access to care for underserved populations, and initiatives addressing social determinants of health such as housing, nutrition, and education.
The public hearing, organized by the Ohio Attorney General's office in collaboration with the Department of Health, is a required step in the approval process for such foundations. Scheduled for July 25, 2025, at a venue in downtown Akron, the event will allow individuals and organizations to voice opinions on the foundation's governance structure, funding priorities, and oversight mechanisms. Attorney General Dave Yost has emphasized the importance of transparency in this process, stating in a recent press release that "the people of Ohio deserve a say in how these funds are used to improve health outcomes for generations to come." Advocates for the hearing argue that it provides a critical check against potential mismanagement or diversion of funds away from local needs.
Background on the Summa sale reveals a complex web of motivations and concerns. HATCo, led by former Intermountain Healthcare CEO Marc Harrison, positions itself as a "health assurance" company focused on leveraging technology and innovation to transform healthcare delivery. Proponents of the deal, including Summa's leadership, argue that the partnership will inject much-needed capital into the system, enabling investments in advanced technologies like AI-driven diagnostics, telehealth expansions, and electronic health record integrations. They contend that without this infusion, Summa risked insolvency or severe service cuts, which could have left gaps in care for vulnerable populations in Akron and beyond.
However, the sale has not been without controversy. Critics, including local unions, patient advocacy groups, and some elected officials, have raised alarms about the potential for profit-driven decisions to prioritize cost-cutting over quality care. For instance, there are fears that HATCo might reduce staffing levels, close unprofitable departments, or increase prices for services, exacerbating healthcare disparities in a region already grappling with high rates of poverty and chronic diseases like diabetes and heart conditions. A coalition of community organizations, led by the Akron-based Health Equity Alliance, has petitioned for stricter conditions on the sale, including guarantees for maintaining charity care levels and protecting employee pensions.
The foundation's creation is seen as a mitigating factor in these debates. Modeled after similar entities formed from past hospital conversions—such as the California Endowment from the Blue Cross of California sale or the Colorado Health Foundation from the HCA divestiture—the Summa foundation could play a pivotal role in offsetting any negative impacts from the for-profit shift. Potential grant areas might include mental health services, opioid addiction treatment, maternal and infant health programs, and workforce development for healthcare professionals. Experts suggest that with prudent management, the foundation could generate annual grants in the tens of millions, rivaling the impact of established philanthropies like the Cleveland Foundation or the Gund Foundation in Northeast Ohio.
To ensure accountability, the hearing will address key governance issues. Who will sit on the foundation's board? How will community representation be ensured? What metrics will measure the foundation's effectiveness? Ohio law mandates that the foundation's assets be used exclusively for health-related charitable purposes within the state, but specifics on geographic focus—whether prioritizing Summit County or expanding statewide—remain up for discussion. Legal experts note that past hearings have led to amendments, such as requiring independent audits or public reporting requirements, to build trust.
Community voices are already mobilizing. Local resident Maria Gonzalez, a longtime Summa patient and advocate for immigrant health access, plans to testify at the hearing. "Summa was built by our community, and its sale shouldn't mean we lose control over how the money helps us," she said in an interview. Similarly, representatives from the Service Employees International Union (SEIU), which represents many Summa workers, intend to highlight job security concerns and push for foundation funds to support retraining programs for displaced employees.
On the other side, supporters of the sale and foundation point to successful precedents. For example, the conversion of Akron's rival system, Akron General, to Cleveland Clinic ownership in 2015 resulted in enhanced services without widespread disruptions. HATCo executives have pledged to maintain Summa's community commitments, including its role as a teaching hospital affiliated with Northeast Ohio Medical University.
As the hearing approaches, broader implications for Ohio's healthcare ecosystem loom large. The state has seen a wave of hospital mergers and acquisitions in recent years, driven by economic pressures and regulatory changes. Summa's sale could set a template for others, such as Mercy Health or University Hospitals, contemplating similar paths. Policymakers in Columbus are watching closely, with some legislators proposing bills to strengthen oversight of nonprofit conversions, including mandatory community benefit assessments.
Economically, the foundation could be a boon for Akron, a city still recovering from the decline of its manufacturing base. Investments in preventive care and health innovation might attract new businesses and talent, fostering a "health tech" corridor in the region. Yet, skeptics warn that without robust public input, the foundation risks becoming another bureaucratic entity detached from grassroots needs.
In preparation for the hearing, the Attorney General's office has released a draft charter for the foundation, available online for public review. Comments can be submitted virtually or in person, ensuring broader participation amid ongoing post-pandemic concerns about large gatherings. The final approval of the foundation is expected by fall 2025, paving the way for its operations to begin in earnest.
This public hearing represents more than a procedural formality; it's a forum for democracy in healthcare decision-making. As Ohio navigates the evolving intersection of profit, philanthropy, and public health, the outcomes could resonate far beyond Akron, influencing how communities across the nation preserve the legacy of their nonprofit institutions in an era of corporate consolidation. Residents are encouraged to engage, as the decisions made now will shape health equity for years to come.
(Word count: 1,048)
Read the Full Cleveland.com Article at:
[ https://www.cleveland.com/medical/2025/07/public-hearing-set-on-health-foundation-tied-to-summa-sale.html ]